Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 3389  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 »   Next article
 »   Previous article
 »   Table of Contents

 Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded454    
    Comments [Add]    
    Cited by others 1    

Recommend this journal


Year : 2007  |  Volume : 55  |  Issue : 2  |  Page : 141--144

Incidence of recurrent stroke in primary care during preventive treatment based on perindopril with or without indapamide

1 Department of Neurology, All India Institute of Medical Sciences, New Delhi, India
2 The Nizam's Institute of Medical Sciences, Hyderabad, India

Correspondence Address:
M V Padma
Department of Neurology, CN Center, All India Institute of Medical Sciences, Ansari Nagar, New Delhi - 110 029
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0028-3886.32785

Rights and Permissions

Background: Although the risk reduction of recurrent stroke with angiotensin converting enzyme-inhibitors with or without a diuretic has been demonstrated under randomized double blind conditions of the PROGRESS study, it is unclear whether the benefit is reflected in primary care practice and in populations with different demographic and clinical characteristics. Aim: To assess the effect and acceptability of perindopril with or without indapamide prevention of recurrent stroke, as reflected by its incidence. Setting and Design: Multicentre, prospective, observational study in the setting of primary care throughout India. Materials and Methods: Patients with a stable stroke or transient ischaemic attack (TIA) received a 12-month perindopril ± indapamide-based regimen, similar to that used in PROGRESS. The principal outcome was the annual incidence of recurrent stroke. Statistical Analysis: Summary statistics and the Kaplan-Meier procedure. Results: The mean age of 298 patients was 58.3 years (SD=12.6). 229 (77.5%) had an ischaemic stroke; 231 (77.5%) were hypertensive; 200 (85.5%) were receiving aspirin and 81 (27.2%) statins. During the 12-month perindopril-based treatment, there were 8 (2.7%) recurrent strokes, with a Kaplan-Meier estimate of strokes plus TIA of 3.3% (95% CI, 1.0-5.6). Conclusions: The incidence of recurrent stroke is similar to that observed under double blind randomized conditions in the treatment arm of the PROGRESS study. This suggests that perindopril ± indapamide-based prevention may be effective in reducing risk of recurrent stroke, (although the uncontrolled study design does not actually demonstrate this), in the setting of day-to-day clinical practice and among patients with different demographic and clinical characteristics than the PROGRESS population.


Print this article     Email this article

Online since 20th March '04
Published by Wolters Kluwer - Medknow